Through joint development with Canadian quantum computer developer D-Wave Systems, Buzzpole has secured exclusive access to the Chinese cervical cancer diagnostic market. [View original text]
With the public's growing demand and expectations for medical care and healthcare, and the healthcare paradigm shifting from post-treatment to proactive prevention and health management, the integration of medical and information and communication technology (ICT) has become essential. The detection and treatment of cervical cancer, a serious threat to women, is particularly crucial. Because mid- to late-stage detection significantly reduces cure rates and can lead to loss of female function, more accurate, high-quality ICT data is crucial. Buzzpole (CEO Jaehoon Jeong), a smart human care company that has been steadily researching medical ICT since its launch in 2014, has developed "CerviClinic AI," an AI-based remote cervical cancer diagnostic system, and is actively advancing its cancer diagnostic engine.
Currently, Buzzpole has secured exclusive access to the Chinese cervical cancer diagnostic market through joint development with Canadian quantum computer developer D-Wave Systems. D-Wave Systems is a world-leading company, supplying quantum computers to companies like Google and NASA. Buzzpole is also actively collaborating with renowned Korean university hospitals. Leveraging Korea's advanced medical technology and developing a lesion classification engine, Buzzpole has already secured state-of-the-art imaging and questionnaire data, a scale that can be commercialized immediately.
As announced by the National IT Industry Promotion Agency on the 29th of last month, leading universities and global ICT companies like Google are freely releasing AI-related source code, and domestic hospitals are also launching their own AI image interpretation solutions. In response, Buzzpole operates its own research center and has partnered with renowned hospitals and specialists both domestically and internationally. Professor Song Jae-yoon of the Department of Obstetrics and Gynecology at Korea University Anam Hospital stated, "We are applying CerviClinic AI to the early diagnosis of cervical cancer to increase the concordance rate between AI diagnostic results and final biopsy results. We are also actively participating in clinical consultation projects for patients from China and Southeast Asia in Korea."
The Thai government is also showing interest in the structure that maximizes synergy by combining Buzzpole's technological prowess with medical professionals working in the industry. They plan to expand their business globally, starting in China as early as May.
2019-04-10 03:00 / Donga.com / Reporter Tae Hyun-ji
